Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Clinical trial NCT04959448 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04959448
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-12
- Primary completion
- 2027-03-25
- Enrollment
- 717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.